Thomas Herdegen

15.3k total citations · 1 hit paper
186 papers, 12.9k citations indexed

About

Thomas Herdegen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Thomas Herdegen has authored 186 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 95 papers in Cellular and Molecular Neuroscience and 26 papers in Physiology. Recurrent topics in Thomas Herdegen's work include Neuroscience and Neuropharmacology Research (52 papers), Nuclear Receptors and Signaling (33 papers) and Melanoma and MAPK Pathways (32 papers). Thomas Herdegen is often cited by papers focused on Neuroscience and Neuropharmacology Research (52 papers), Nuclear Receptors and Signaling (33 papers) and Melanoma and MAPK Pathways (32 papers). Thomas Herdegen collaborates with scholars based in Germany, United States and Czechia. Thomas Herdegen's co-authors include J.D. Leah, Vicki Waetzig, M. Zimmermann, Kirsten Mielke, R Bravo, Stephan Brecht, Yi Zhao, Rodrigo Bravo, Juraj Čulman and Marika Kiessling and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

Thomas Herdegen

185 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins

1998 1.2k citations Thomas Herdegen, J.D. Leah profile →

Peers

Countries citing papers authored by Thomas Herdegen

Since Specialization

Citations

This map shows the geographic impact of Thomas Herdegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Herdegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Herdegen more than expected).

Fields of papers citing papers by Thomas Herdegen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Herdegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Herdegen. The network helps show where Thomas Herdegen may publish in the future.

Co-authorship network of co-authors of Thomas Herdegen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Herdegen. A scholar is included among the top collaborators of Thomas Herdegen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Herdegen. Thomas Herdegen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs 2023 ·Deutsches Ärzteblatt international ·Thomas Herdegen, Ingolf Cascorbi	7
2	The IL-33-induced p38-/JNK1/2-TNFα axis is antagonized by activation of β-adrenergic-receptors in dendritic cells 2020 ·Scientific Reports ·(unknown), (unknown), Nico Andreas, Thomas Herdegen, Matthias Gaestel, Thomas Kamradt, Sebastian Drube	7
3	Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series 2014 ·Scandinavian Journal of Pain ·H. Wernze, Thomas Herdegen	6
4	Oxidative Stress Induces Biphasic ERK1/2 Activation in the RPE with Distinct Effects on Cell Survival at Early and Late Activation 2014 ·Current Eye Research ·Stefan Koinzer, Kirstin Reinecke, Thomas Herdegen, Johann Roider, Alexa Klettner	30
5	Miswiring the brain: 9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway 2014 ·The EMBO Journal ·Giuseppe Tortoriello, Caroline Morris, Alán Alpár, János Fuzik, Sally L. Shirran, Daniela Calvigioni, Erik Keimpema, Catherine H. Botting, Kirstin Reinecke, Thomas Herdegen, Michael J. Courtney, Yasmin L. Hurd, Tibor Harkany	174
6	Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain 2010 ·Journal of Hypertension ·Torben Glatz, (unknown), (unknown), Peter Gohlke, Thomas Herdegen, Juraj Čulman, Yi Zhao	50
7	The c-Jun N-terminal kinase (JNK) inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats 2009 ·Neuropathology and Applied Neurobiology ·(unknown), Yi Zhao, Andreas Patzer, (unknown), (unknown), Günther Deuschl, Juraj Čulman, Christophe Bonny, Thomas Herdegen, Christoph Eschenfelder	29
8	Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner 2008 ·Journal of Neuroscience Methods ·Stephan Ulmer, Matthias Reeh, (unknown), Thomas Herdegen, Janka Held‐Feindt, Olav Jansen, Axel Rohr	14
9	Genetic Deletion of JNK1 and JNK2 Aggravates the DSS-Induced Colitis in Mice 2007 ·Journal of Investigative Surgery ·Ansgar M. Chromik, Annette Müller, Judith Körner, Orlin Belyaev, Tim Holland‐Letz, Frank Schmitz, Thomas Herdegen, Waldemar Uhl, U. Mittelkötter	28
10	JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length 2006 ·The Journal of Cell Biology ·(unknown), (unknown), Wenrui Li, Benny Björkblom, Artur Padzik, Justyna Zdrojewska, Vesa Hongisto, Thomas Herdegen, Witold Konopka, Michael J. Courtney, Eleanor T. Coffey	154
11	The bright side of JNKs—Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration 2006 ·Progress in Neurobiology ·Vicki Waetzig, Yi Zhao, Thomas Herdegen	114
12	JNK2 Translocates to the Mitochondria and Mediates Cytochrome c Release in PC12 Cells in Response to 6-Hydroxydopamine 2004 ·Journal of Biological Chemistry ·(unknown), Alexa Klettner, (unknown), Thomas Herdegen, Vicki Waetzig	92
13	The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle 1999 ·Neuroscience ·Christine Winter, Johannes Schenkel, Erich Bürger, Christian Eickmeier, M. Zimmermann, Thomas Herdegen	53
14	MAP kinase phosphatase 1 is expressed and enhanced by FK506 in surviving mamillary, but not degenerating nigral neurons following axotomy 1998 ·Brain Research ·(unknown), Johannes Schenkel, M. Zimmermann, Thomas Herdegen	17
15	Trophic Factor Modulation of c-Jun Expression in Supraspinal Neurons after Chronic Spinal Cord Injury 1998 ·Experimental Neurology ·John D. Houlé, Peter Schramm, Thomas Herdegen	27
16	Induction of FOS and JUN proteins during focal epilepsy: congruences with and differences to [14C]deoxyglucose metabolism 1997 ·Molecular Brain Research ·P. Gass, C. Bruehl, Thomas Herdegen, Marika Kiessling, Michael Lutzenburg, Otto W. Witte	23
17	Transection of Rat Fimbria-Fornix Induces Lasting Expression of c-Jun Protein in Axotomized Septal Neurons Immunonegative for Choline Acetyltransferase and Nitric Oxide Synthase 1995 ·Experimental Neurology ·Stephan Brecht, Ana Martín-Villalba, Werner Zuschratter, Rodrigo Bravo, Thomas Herdegen	30
18	Concurrent immediate early gene induction by epileptic seizures in heterotopic cortical grafts and neocortex 1994 ·Molecular Brain Research ·Sylvia Bele, Peter Gass, Thomas Herdegen, Rodrigo Bravo, Marika Kiessling	10
19	Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat central nervous system 1993 ·Neuroscience ·J.D. Leah, Thomas Herdegen, Alexander K. Murashov, Mike Dragunow, R Bravo	82
20	The transcription factors c-JUN, JUN D and CREB, but not FOS and KROX-24, are differentially regulated in axotomized neurons following transection of rat sciatic nerve 1992 ·Molecular Brain Research ·Thomas Herdegen, (unknown), Wolfgang Schmid, Rodrigo Bravo, M. Zimmermann	182

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact